Lv3
350 积分 2024-08-22 加入
Advances in sarcoma gene mutations and therapeutic targets
5小时前
已完结
BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?
23天前
已完结
Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell‐Induced Ferroptosis in Ovarian Cancer
23天前
已完结
Newest glue degrader nabs multiple myeloma approval
23天前
已完结
Human and mouse early B cell development: So similar but so different
23天前
已完结
PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
28天前
已完结
Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non‐Hodgkin lymphoma
1个月前
已完结
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
1个月前
已完结
Novel therapeutic strategies targeting resistance mechanisms in hematologic malignancies: from BCL2 inhibition to immunomodulatory approaches
1个月前
已完结
Bruton’s Tyrosine Kinase Inhibitors: Recent Updates
1个月前
已完结
皖公网安备34019202002308
